New Reports on Healthcare Market Now Available at MarketPublishers.com
11 Jul 2022 • by Natalie Aster
LONDON - Market Publishers boast a sizeable collection of in-demand research reports covering the healthcare market, which is regularly replenished with cutting-edge publications from our research partners. These studies offer a clear understanding of the examined markets landscape, provide access to reliable data on historical and current scenarios, discuss prevailing and emerging trends, highlight the major growth opportunities and challenges, identify future growth prospects, touch upon the competitive environment and top players, uncover cutting-edge statistics and market data, and provide other important information on the market performance.
Here is a selection of the most popular research reports on the healthcare market recently added at MarketPublishers.com:
Orphan Cancer drugs are novel pharmaceuticals that are indicated for the prevention, diagnosis, or treatment of rare cancers. These rare cancers are chronic and life-threatening, and require proper long-term medications. As these diseases are rare, therefore, drug development in this field requires a considerable amount of investment, thus increasing the overall cost of the drugs. Presently, the global orphan cancer drugs market is highly concentrated with several key players, including Mersana Therapeutics, Bristol Myers Squibb, Immunocore, Amgen, Genmab, Roche, Lava Therapeutics, and others. The world’s orphan cancer drugs market is anticipated to cross USD 150 billion in value terms by the year 2028, driven by the increasing prevalence of rare cancers along with the strong demand for orphan drugs in its management…
The introduction of vaccines for the prevention of infectious disease represents one of the greatest achievements in modern medicine. Owing to their advantages, research studies have also focused to explore the potential of vaccines in the prevention or management of chronic diseases including cancer. cancer vaccine represents a unique approach to cancer therapy that alters the interaction of the host and the tumor, enlisting the patient’s tumor response to attack cancer cells. Further, the immunologic memory associated with the administration of vaccines also gained the interest of researchers to invest in this segment. Both therapeutic as well as preventive cancer vaccines have already entered the global market. Presently, the pipeline of cancer vaccines is highly crowded, many products are reporting encouraging success in clinical trials across a wide range of cancers. Several vaccines are also awaiting marketing approval or commercialization. The global cancer vaccine market is poised to cross USD 15 billion by the year 2028…
The world’s market for tissue diagnostics is slated to expand at a 6.6% CAGR between 2022 and 2027, spurred by the increasing prevalence of neoplastic cases coupled with strong demand for oncology screening. Meantime, the lack of skilled professionals will likely act as the key challenge for the market growth. By 2027, the market value is expected to reach USD 7.3 billion. Asia-Pacific is predicted to be the fastest growing regional market for tissue diagnostics during the forecast period, driven by the rising prevalence of chronic diseases, large population base, mounting demand for quality medical care, increasing healthcare spending, favourable initiatives, and enhancing awareness of tissue diagnostic tests…
In 2021, the global analgesics market was evaluated at around USD 77.3 billion. During 2022-2028, this market is projected to demonstrate healthy growth at a CAGR of around 5.6%, driven by the ongoing advancements in pain management measures, expanding manufacturing facilities, and increasing prevalence of chronic and neuropathic pain. Moreover, the commercialization of opioid-tolerant drugs and the introduction of non-opioid analgesics will likely boost the analgesics market growth during the next 6 years. However, rising cases of opioid misuse and government restrictions on the sale and prescription of opioids may restrain the market growth over the projection period…
Lymphoma Antibody Therapeutics Market
In the last few years, remarkable progress has been made in the field of immunotherapy. Multiple immunotherapeutic approaches based on various targeting mechanisms have emerged as standard treatment options for the management of a wide range of cancers, including lymphoma. Among all approaches, antibody-based immunotherapy is considered the main component of lymphoma therapy, alongside surgery, radiation, and chemotherapy. The world’s lymphoma antibody therapeutics market is poised to register impressive growth, driven by high unmet clinical needs associated with the disease and emerging product launches. By the year 2028, the value of the global lymphoma antibody therapeutics market is anticipated to amount to USD 6 billion…
Lung Cancer Antibody Therapeutics Market
The increased understanding of the human immune system and the introduction of immune modulation techniques have led to the development of a new era of immunotherapy in the management of lung cancer. Extensive R&D activities have resulted in the development of several immunotherapeutic approaches including checkpoint inhibitors, vaccines, therapeutic antibodies, immunomodulators, and others. The huge clinical success of antibody therapeutics in the management of lung cancer acts as the key driver of the global lung cancer antibody therapeutics market, which is projected to amount to a value of USD 10 billion by the year 2028. The rising incidence of lung cancer conditions, soaring popularity of advanced antibody therapies, and the rapidly growing geriatric population. Meantime, high costs associated with new drug development along with threats of failure and adverse effects associated with lung cancer antibody therapies may restrain the growth of the market in the coming years…
The global breast biopsy market is projected to follow an upward trend in the next 3 years, registering a CAGR of 8.56%. Robust growth in this market will likely be spurred by the increasing prevalence of breast cancer, and growing proportion of the female population aged 65+. Besides, the rising adoption of liquid biopsy is expected to have positive impact on the overall breast biopsy market in the coming years. In 2025, the value of the global breast biopsy market is anticipated to come to USD 1.75 billion. North America is poised to command the leading share of the global breast biopsy market over 2022-2025, followed by Europe and Asia-Pacific…
Many other topical research studies can be found in the Healthcare Market Reports Catalogue.
Analytics & News
